Angioimmunoblastic T-cell Lymphoma Clinical Trials in Xuzhou, Jiangsu
2 recruitingXuzhou, Jiangsu, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of New Diagnosed AITL
New Diagnosed Angioimmunoblastic T-Cell Lymphoma
The Affiliated Hospital of Xuzhou Medical University40 enrolled1 locationNCT07168317
Recruiting
Phase 2
Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of R/R AITL
Angioimmunoblastic T-Cell Lymphoma RecurrentAngioimmunoblastic T-Cell Lymphoma Refractory
The Affiliated Hospital of Xuzhou Medical University40 enrolled1 locationNCT07058103